BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2526715)

  • 1. Erythroderma from carbamazepine.
    Romaguera C; Grimalt F; Vilaplana J; Azon A
    Contact Dermatitis; 1989 Apr; 20(4):304-5. PubMed ID: 2526715
    [No Abstract]   [Full Text] [Related]  

  • 2. [Erythroderma caused by carbamazepine. Diagnosis with skin patch].
    Blasco Sarramían A; Pinilla Moraza J; Atares Pueyo MB; Lobera Labairu T; Izquier-Do Cuartero MA; San Román Lazcano FJ
    An Med Interna; 1993 Jul; 10(7):341-2. PubMed ID: 8218768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unusual combination of erythroderma and agranulocytosis induced by carbamazepine.
    Tayoro J; Jonville-Béra AP; Dequin PF; Autret E; Perrotin D
    Therapie; 1998; 53(5):513-4. PubMed ID: 9921051
    [No Abstract]   [Full Text] [Related]  

  • 4. [Erythroderma and hepatitis].
    Penela Vélez de Guevara MT; Puente Sánchez MC; Jiménez Moya AI; Herrera Martín M; Romero Escós MD
    An Pediatr (Barc); 2004 Oct; 61(4):353-4. PubMed ID: 15456599
    [No Abstract]   [Full Text] [Related]  

  • 5. Exfoliative dermatitis due to immunologically confirmed carbamazepine hypersensitivity.
    Troost RJ; Oranje AP; Lijnen RL; Benner R; Prens EP
    Pediatr Dermatol; 1996; 13(4):316-20. PubMed ID: 8844754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Erythroderma caused by carbamazepine].
    Granier F; Jay P; Mauduit G; Hermier C; Thivolet J
    Rev Med Interne; 1987; 8(2):206-7. PubMed ID: 2954198
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbamazepine induced erythroderma with systemic lymphadenopathy.
    Okuyama R; Ichinohasama R; Tagami H
    J Dermatol; 1996 Jul; 23(7):489-94. PubMed ID: 8772031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patch testing in cutaneous reactions caused by carbamazepine.
    Alanko K
    Contact Dermatitis; 1993 Nov; 29(5):254-7. PubMed ID: 8112065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute renal failure and erythroderma caused by carbamazepine therapy].
    Ruiz Ezquerro JJ; Arcaya Navarro J; Díaz Molina H; Sánchez Estella J; de Diego Gómez JM
    An Med Interna; 1990 Apr; 7(4):216-7. PubMed ID: 2151749
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dysimmune lymphadenopathy, erythroderma and hematologic disorders during carbamazepine treatment].
    Gaulier A; Marsan C; Sigal S; Perron J; Loutre JC
    Nouv Presse Med; 1980 Apr; 9(19):1388. PubMed ID: 6446081
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute renal insufficiency, erythroderma and polyadenopathy during treatment with carbamazepine].
    Chennebault JM; Dumont AM; Achard J; Alquier P; Saint-Adré JP
    Therapie; 1982; 37(1):106. PubMed ID: 6211795
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum interferon-gamma level in a patient with carbamazepine-induced erythroderma.
    Koga T; Imayama S; Hori Y
    Contact Dermatitis; 1995 Oct; 33(4):275. PubMed ID: 8654088
    [No Abstract]   [Full Text] [Related]  

  • 13. Carbamazepine induced eczematous eruption-clinically resembling atopic dermatitis.
    Ozkaya-Bayazit E; Güngör H
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):182-3. PubMed ID: 10343956
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic pustuloderma--a new entity?
    Staughton RC; Payne CM; Harper JI; McMichen H
    J R Soc Med; 1984; 77 Suppl 4(Suppl 4):6-8. PubMed ID: 6239924
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythroderma secondary to gliclazide: a case report.
    Ozuguz P; Kacar SD; Ozuguz U; Karaca S; Tokyol C
    Cutan Ocul Toxicol; 2014 Dec; 33(4):342-4. PubMed ID: 24641117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure.
    Ray-Chaudhuri K; Pye IF; Boggild M
    Neurology; 1989 Mar; 39(3):436-8. PubMed ID: 2522601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine-associated exfoliative dermatitis.
    Reed MD; Bertino JS; Blumer JL
    Clin Pharm; 1982; 1(1):78-9. PubMed ID: 6223779
    [No Abstract]   [Full Text] [Related]  

  • 18. Propolis-induced erythroderma.
    Horiuchi Y
    J Dermatol; 2001 Oct; 28(10):580-1. PubMed ID: 11732731
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed carbamazepine--induced exfoliative erythrodermia.
    Blin O; Sangla I; Serratrice G
    Therapie; 1991; 46(1):91. PubMed ID: 1826972
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dermatitis exfoliativa caused by carbamazepine].
    Giménez García RM; Sanz Santacruz C
    Rev Clin Esp; 1987 Dec; 181(9):542-3. PubMed ID: 2966420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.